| Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial T Strowitzki, J Marr, C Gerlinger, T Faustmann, C Seitz Human Reproduction 25 (3), 633-641, 2010 | 503 | 2010 |
| Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study T Strowitzki, T Faustmann, C Gerlinger, C Seitz European Journal of Obstetrics & Gynecology and Reproductive Biology 151 (2 …, 2010 | 315 | 2010 |
| Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment F Petraglia, D Hornung, C Seitz, T Faustmann, C Gerlinger, S Luisi, ... Archives of gynecology and obstetrics 285, 167-173, 2012 | 268 | 2012 |
| A dose-ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis G Köhler, TA Faustmann, C Gerlinger, C Seitz, AO Mueck International Journal of Gynecology & Obstetrics 108 (1), 21-25, 2010 | 254 | 2010 |
| A dose‐ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis G Köhler, TA Faustmann, C Gerlinger, C Seitz, AO Mueck International Journal of Gynecology & Obstetrics 108 (1), 21-25, 2010 | 254 | 2010 |
| Defining a minimal clinically important difference for endometriosis-associated pelvic pain measured on a visual analog scale: analyses of two placebo-controlled, randomized trials C Gerlinger, U Schumacher, T Faustmann, A Colligs, H Schmitz, C Seitz Health and quality of life outcomes 8, 1-7, 2010 | 136 | 2010 |
| Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program T Strowitzki, T Faustmann, C Gerlinger, U Schumacher, C Ahlers, C Seitz International journal of women's health, 393-401, 2015 | 130 | 2015 |
| A systematic review of methods to measure menstrual blood loss JL Magnay, S O’Brien, C Gerlinger, C Seitz BMC Women's Health 18, 1-13, 2018 | 116 | 2018 |
| Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis T Strowitzki, J Marr, C Gerlinger, T Faustmann, C Seitz International Journal of Gynecology & Obstetrics 117 (3), 228-233, 2012 | 116 | 2012 |
| Dienogest 2 mg daily in the treatment of adolescents with clinically suspected endometriosis: the VISanne study to assess safety in ADOlescents AD Ebert, L Dong, M Merz, B Kirsch, M Francuski, B Böttcher, H Roman, ... Journal of pediatric and adolescent gynecology 30 (5), 560-567, 2017 | 112 | 2017 |
| Validation of the SF-36 in patients with endometriosis DE Stull, R Wasiak, N Kreif, M Raluy, A Colligs, C Seitz, C Gerlinger Quality of life research 23, 103-117, 2014 | 88 | 2014 |
| Pictorial methods to assess heavy menstrual bleeding in research and clinical practice: a systematic literature review JL Magnay, S O’Brien, C Gerlinger, C Seitz BMC women's health 20, 1-15, 2020 | 84 | 2020 |
| The monoclonal antibody HCA2 recognises a broadly shared epitope on selected classical as well as several non-classical HLA class I molecules C Seitz, B Uchanska-Ziegler, A Zank, A Ziegler Molecular immunology 35 (13), 819-827, 1998 | 61 | 1998 |
| Process for producing a pharmaceutical preparation for therapeutic treatment of endometriosis containing a combination of a gestagen and (6s)-5-methyltetrahydrofolate C Seitz, A Wasserfall, H Zimmermann, K Diefenbach, K King US Patent App. 12/185,456, 2009 | 58 | 2009 |
| Pharmaceutical preparation containing a gestagen, and kit and method for treating endometriosis using the preparation C Seitz, A Wasserfall, H Zimmermann US Patent App. 12/037,990, 2008 | 55 | 2008 |
| Treatment of endometriosis in different ethnic populations: a meta-analysis of two clinical trials C Gerlinger, T Faustmann, JJ Hassall, C Seitz BMC women's health 12, 1-7, 2012 | 50 | 2012 |
| Validation of a new menstrual pictogram (superabsorbent polymer-c version) for use with ultraslim towels that contain superabsorbent polymers JL Magnay, TM Nevatte, S O'Brien, C Gerlinger, C Seitz Fertility and sterility 101 (2), 515-522. e5, 2014 | 48 | 2014 |
| Pharmacodynamics and safety of the novel selective progesterone receptor modulator vilaprisan: a double-blind, randomized, placebo-controlled phase 1 trial in healthy women B Schütt, A Kaiser, MH Schultze-Mosgau, C Seitz, D Bell, M Koch, ... Human Reproduction 31 (8), 1703-1712, 2016 | 46 | 2016 |
| Efficacy and safety of elinzanetant, a selective neurokinin-1, 3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1) JA Simon, RA Anderson, E Ballantyne, J Bolognese, C Caetano, H Joffe, ... Menopause 30 (3), 239-246, 2023 | 37 | 2023 |
| Development and content validation of two new patient-reported outcome measures for endometriosis: the Endometriosis Symptom Diary (ESD) and Endometriosis Impact Scale (EIS) A Gater, F Taylor, C Seitz, C Gerlinger, K Wichmann, C Haberland Journal of Patient-Reported Outcomes 4, 1-17, 2020 | 32 | 2020 |
Adam GaterSenior Director - Patient-Centered Outcomes, Adelphi ValuesVerified email at adelphivalues.com